Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSemaglutide tablets are a once-daily oral form of the same medicine found in the Wegovy and Ozempic injections. In the UK, the first oral semaglutide licensed for weight management was approved by the MHRA on 11 June 2026, taken as a tablet each morning on an empty stomach. It is a prescription-only medicine that a prescriber must assess you for. Below, we clear up the confusion this topic tends to create and set out what actually applies here.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common assumption we hear is that a tablet is a softer, watered-down version of the jab. It isn't. Semaglutide is semaglutide, whether it reaches your bloodstream through a needle once a week or through a tablet you swallow each morning. The molecule doing the work is identical.
What differs is the delivery. Semaglutide is a large peptide that the gut would normally break down before it could be absorbed, so the oral version is co-formulated with an absorption enhancer called SNAC that protects it and helps it cross the stomach lining. That's the clever part of the tablet, not a compromise on the drug itself.
The doses look different because they're measured differently. The Wegovy weight-loss tablet climbs to a 25mg daily maintenance dose, while the injection tops out at 2.4mg weekly, but you can't compare those numbers head to head because absorption through the gut is far less efficient than a subcutaneous injection. A bigger tablet number does not mean a bigger effect. If you want the fuller picture on how the two formats stack up in practice, our page on semaglutide tablets versus the injection walks through it. So the honest headline is this: same medicine, different route, and if you're wondering whether you can get Wegovy in pill form, the answer is yes, and the choice between formats is clinical, not a question of strength.
This is where most searches go wrong, because two different tablets share the same active ingredient. Getting them straight matters.
Wegovy tablets (semaglutide co-formulated with SNAC) were approved by the MHRA on 11 June 2026 as the first oral GLP-1 medicine licensed in the UK for weight management. The UK was the first country in Europe to license it. It's authorised for adults with a BMI of 30 or above, or 27 to 29.9 with at least one weight-related condition, taken alongside a reduced-calorie diet and more physical activity.
Rybelsus is also oral semaglutide, but it's licensed for type 2 diabetes and comes in 3mg, 7mg and 14mg strengths. Those diabetes strengths are not steps on the weight-loss tablet ladder, and it's a genuinely important distinction. If your search brought you to a page about the 3mg semaglutide tablet or the 14mg tablet, those figures belong to the diabetes product, not the weight-management one. We set the two apart clearly on our Rybelsus semaglutide tablets page.
So when someone asks about semaglutide tablets in the UK for weight loss, the answer is Wegovy tablets. If you've seen the older name for oral semaglutide mentioned online, our note on the names semaglutide tablets go by untangles it. Getting the right product is the first thing our prescribers confirm.
Semaglutide is a GLP-1 receptor agonist. It mimics a natural gut hormone called GLP-1, which your body releases after eating. That hormone tells your brain you're full, slows how quickly your stomach empties, and helps steady blood-sugar levels. In practical terms, most people find they feel satisfied sooner and stay satisfied for longer, so they eat less without white-knuckling through hunger.
The tablet delivers that same signalling as the injection, just on a daily rhythm instead of a weekly one. Because a steady daily dose keeps the medicine topped up, missing the timing window matters more with tablets than with a weekly pen, which is one reason the taking instructions are so specific.
Here's how it's taken, and it's non-negotiable for it to work properly: first thing in the morning, on a genuinely empty stomach, with no more than a small sip of plain water. Then you wait at least 30 minutes before any food, any other drink including coffee, and any other tablets. The kettle stays off for half an hour. Swallow it whole; don't split or crush it. If you'd like the mechanism explained in more depth, we cover how well semaglutide tablets work and how long they take to work on their own pages. The NHS overview of semaglutide as a medicine is a solid plain-English starting point too. The short version: it works with your appetite, not against your willpower.
The weight-management tablet was tested in a phase 3 trial called OASIS 4, which followed 307 adults who had obesity, or were overweight with at least one weight-related condition, and did not have diabetes. They took the tablet alongside lifestyle changes for 64 weeks, compared against a placebo.
On average, participants lost around 13.6% of their body weight, against roughly 2.4% on placebo. Among those who stayed fully adherent to the treatment throughout the trial, average loss reached about 17%. That higher figure is worth understanding correctly: it reflects people who stuck with the regimen closely, not a guaranteed outcome for everyone, and adherence with a daily empty-stomach tablet takes some routine-building.
For context, the semaglutide injection at 2.4mg produced roughly 15% average loss in its own STEP 1 trial over 68 weeks, so oral and injectable semaglutide land in broadly similar territory when taken as directed. Results in a trial are averages across a group, and your own response depends on your starting point, your health and how the medicine suits you. We keep the numbers and the framing straight on our page about semaglutide tablets for weight loss. None of this is a promise of a specific result, and a prescriber will talk you through what's realistic for you rather than quoting a trial figure as a target.
Most side effects of oral semaglutide are digestive, and most are mild to moderate and temporary. In the OASIS 4 trial, gastrointestinal effects were reported by around 74% of people on the tablet compared with about 42% on placebo, and they were generally the sort that ease as your body adjusts.
The ones people notice most are nausea, an unsettled stomach, changes to how often you go, reflux or indigestion, and sometimes tiredness or a mild headache. These tend to be most obvious when you first start and after each dose increase, and for many people they fade within days to a couple of weeks. Eating smaller, less rich meals and keeping fluids up often helps in that early window.
There's one uncommon but serious effect to know about. In January 2026 the MHRA reminded prescribers and patients that GLP-1 medicines carry a small risk of acute pancreatitis. If you get severe, persistent stomach pain that may spread through to your back, with or without vomiting, treat it as urgent and seek medical help straight away. Our dedicated page on semaglutide tablet side effects goes through the full picture, and you can report any suspected side effect through the MHRA Yellow Card scheme. Being told what to expect early is the thing patients most often say made the difference.
The licensed starting point is straightforward: adults with a BMI of 30 or above, or a BMI of 27 to 29.9 who also have a weight-related condition such as high blood pressure, high cholesterol, prediabetes, type 2 diabetes or obstructive sleep apnoea. Lower BMI thresholds can apply for people from some ethnic backgrounds under UK guidance, reflecting different health risks at a given BMI.
BMI on its own never settles it, though. A prescriber looks at your full health history, your current medicines and your goals before deciding whether the tablet is appropriate. That's the point of a proper assessment rather than a box-ticking exercise, and you can read how our clinical oversight works on our page about our clinical team.
Some people are not suitable. Oral semaglutide is not recommended in pregnancy or while breastfeeding, and it isn't for anyone trying to conceive; it's also not licensed for under-18s. A personal or family history of medullary thyroid cancer, a history of pancreatitis, and certain gut conditions all need to be talked through with a prescriber first. The MHRA also advises using contraception while taking GLP-1 medicines and allowing a wash-out period before trying for a baby. If you're weighing up your options generally, our weight-loss treatment overview sets out what's available. Suitability is a conversation, not a formula, and it's one worth having honestly.
The only lawful way to obtain semaglutide tablets in the UK is with a prescription, following a proper clinical assessment. There is no over-the-counter route, and no legitimate seller will hand these out without one. Anyone offering them without a prescription, without any clinical questions, or at a price far below the market should be treated as a warning sign.
The medicine is prescription-only, so a registered prescriber must review your suitability first. With nume, that means a free consultation you complete online, which is then read the same day by a GPhC-registered Independent Prescriber, not sorted by software. We verify your identity with photo ID and confirm your weight on video, and we notify your GP in line with pharmacy guidance. If treatment is clinically approved and you order before 12pm on a working day, it's dispatched the same day for free next-working-day delivery by DPD, so what turns up is a plain, unbranded box you can track on your phone.
You can always check that an online pharmacy is legitimate on the GPhC register before you buy anything. The MHRA has warned repeatedly about fake weight-loss products sold online and through social media, with large seizures of counterfeit pens in recent years. If you want the practical steps, our guide to getting semaglutide tablets online lays them out. The right question isn't who's cheapest; it's who's genuinely regulated.
On the NHS, semaglutide tablets for weight loss are not currently available. Because they were only licensed by the MHRA in June 2026, a separate NICE appraisal would need to happen before the NHS could routinely fund them, and that process takes time. For now, the tablet is a private prescription option.
The semaglutide injection does exist on the NHS, but through specialist weight-management services under strict criteria, and waiting lists for those services are commonly long. Tirzepatide is being phased into NHS prescribing too, starting with the highest-need groups and rolling out gradually, with availability varying by area and by GP practice. Meeting the clinical criteria doesn't guarantee quick access, and everyone treated on the NHS is expected to take part in wraparound diet and activity support. You can read NHS England's own explanation of weight-management medicines on the NHS for the detail.
So the honest position is this: NHS routes are real but narrow and slow, and the tablet isn't on them yet. A regulated private route is the alternative for people who don't meet the NHS thresholds, or don't want to wait months. We're not the NHS and we'd never claim to be; we're a regulated online pharmacy that offers a different path. If you'd rather compare the format that's more established, our Wegovy pill page covers the same tablet from that angle.
Private weight-loss treatment in the UK is priced per month and varies between providers, and any legitimate price should already include the prescription and the clinical assessment behind it. As a point of reference, the wider semaglutide and tirzepatide market has typically ranged from roughly £149 to £375 a month depending on dose and provider since list prices rose in late 2025.
What a low headline figure often leaves out is the rest: consultation fees, prescription fees, delivery charges, and any dose-review support. When those get added back on, the cheapest-looking option isn't always the cheapest, and it certainly isn't always the safest. We're upfront that we don't compete to be the lowest price on the page; that's a deliberate choice, not an accident.
With nume, one transparent price covers the free consultation, the free prescription, your treatment, free next-working-day tracked delivery and priority aftercare seven days a week. There are no subscriptions and no auto-renewals; every repeat order is clinically re-reviewed before it goes anywhere. You'll find current treatment pricing on our weight-loss treatments page, and a fuller breakdown on our semaglutide tablets price page. For a prescription medicine, the price tag is the wrong test to judge it by. Genuine supply, real clinical oversight and proper aftercare are the measures that keep you safe, and those are the ones worth checking.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.